Our data indicate that the beneficial effects of pioglitazone therapy in PCOS may include improved protein metabolism mediated either via an enhanced anabolic action of insulin or directly via PPARγ by an as yet unknown mechanism. This evidence concerns the gene PPARG and polycystic ovary syndrome.